Clinical Trials Logo

Filter by:
NCT ID: NCT03650764 Active, not recruiting - Clinical trials for Head and Neck Squamous Cell Carcinoma

Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Start date: May 29, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The investigators hypothesize that inhibition of angiogenesis and PD-1 will be more effective than inhibition of PD-1 alone. The first step in pursuing proof of this hypothesis is to establish the safety and feasibility of combining ramucirumab with pembrolizumab, therefore the first part of this protocol is a de-escalation phase I trial of the combination of ramucirumab + pembrolizumab. The key objective of the phase I trial is to establish the safety and the recommended phase 2 dose (RP2D) of ramucirumab for this novel combination regimen in patients with recurrent/metastatic head and neck squamous cell carcinoma (RM-HNSCC). The second step in pursuing proof of this hypothesis is to establish the efficacy of ramucirumab (using the RP2D) with pembrolizumab. The second part of this protocol is a single arm phase II trial combining ramucirumab + pembrolizumab. The primary objective of the phase II trial is to determine the tumor response rates (complete response (CR) and partial response (PR)) of the treatment combination given as first line therapy in patients with RM-HNSCC.

NCT ID: NCT03649958 Active, not recruiting - Insomnia Clinical Trials

Neurotechnology Following Traumatic Brain Injury

Cereset
Start date: August 28, 2018
Phase: N/A
Study type: Interventional

This two-part study seeks to improve symptoms such as pain and sleep problems after concussion, or mild traumatic brain injury (mTBI). Study I evaluates symptoms of mTBI through a series of 10 office sessions in which musical tones are echoed, or mirrored back in real time, to reflect one's own brain activity. Those who take part in the study will be randomly assigned to receive either tones that are based on their brain activity/brainwaves, or random tones. Study II evaluates symptoms of mTBI through either 10 office sessions of the same acoustic stimulation linked to brain activity/brainwaves as Study I compared to 5 office sessions of acoustic stimulation plus intermittent very low level electrical stimulation of the scalp linked to brain activity.

NCT ID: NCT03649776 Active, not recruiting - Stigma Clinical Trials

Training Church Leaders in Mental Health First Aid

Start date: February 27, 2016
Phase:
Study type: Observational

The purpose of this study is to train Church Leaders and other community members in Mental Health First Aid (MHFA), which is an evidence-based public mental health education program. MHFA has been found to improve people's recognition of emotional and mental health challenges and to increase people's confidence in providing help to others. Information about MHFA can be accessed at http://www.mentalhealthfirstaid.org. MHFA consists an 8-hour training program in which participants will be provided a manual, learn the signs and symptoms of common mental health problems, and learn a 5-step action plan to help someone in an emotional crisis. Participants ware recruited from faith-based organizations (i.e., churches), health care organizations (i.e., hospitals), and other community based organizations. There will be no treatment directly provided as part of this study.

NCT ID: NCT03649555 Active, not recruiting - Healthy Controls Clinical Trials

Reliability of [18F]-FTC-146 Brain Uptake in Healthy Controls

rSIG
Start date: February 1, 2019
Phase: Phase 1
Study type: Interventional

The purpose of this study is to understand the reliability of [18F]-FTC-146 brain uptake in healthy controls.

NCT ID: NCT03649178 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

Dietary Salt in Rheumatoid Arthritis

Start date: January 2, 2020
Phase: N/A
Study type: Interventional

In this study investigators propose to address the following hypotheses: 1) Reduction in dietary sodium will decrease inflammation in patients with rheumatoid arthritis (RA). 2) Reduction in dietary sodium will decrease blood pressure in patients with RA. 3) Reduction in dietary sodium will decrease tissue sodium in patients with RA.

NCT ID: NCT03648710 Active, not recruiting - Sickle Cell Disease Clinical Trials

Community Health Workers and mHealth for Sickle Cell Disease Care

Start date: January 15, 2019
Phase: N/A
Study type: Interventional

This study will compare the effectiveness of two self-management support interventions-Community Health Workers (CHW) and mobile health (mHealth)-versus enhanced usual care to improve health-related quality of life and acute care use for transitioning youth with sickle cell disease (SCD), and identify and quantify mediators and moderators of intervention treatment effects.

NCT ID: NCT03648385 Active, not recruiting - Clinical trials for Pulmonary Arterial Hypertension

Effects of DHEA in Pulmonary Hypertension

EDIPHY
Start date: January 9, 2019
Phase: Phase 2
Study type: Interventional

The goal of this crossover trial is to determine whether the study drug dehydroepiandrosterone (DHEA) improves right ventricular longitudinal strain measured by cardiac magnetic resonance imaging at 18 weeks compared to placebo and to assess side effects and safety in pulmonary arterial hypertension.

NCT ID: NCT03647306 Active, not recruiting - Clinical trials for Cardiovascular Diseases

Behavioral Chronotype: Impact on Sleep and Metabolism

Start date: February 2, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to examine how the timing of eating changes how the body makes and uses energy (metabolism). This study will also examine if metabolism changes with age.

NCT ID: NCT03646643 Active, not recruiting - Atrial Fibrillation Clinical Trials

Prospective Elimination Of Distal Coronary Sinus-Left Atrial Connections for Atrial Fibrillation Ablation Trial

PRECAF
Start date: August 18, 2018
Phase: N/A
Study type: Interventional

Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting millions of people in the US and around the world. Over the last 20 years, catheter based AF ablation has been widely adopted offering improved symptom control for many patients worldwide. However, long-term success rates remain suboptimal. Prior work indicates that distal connections between coronary sinus musculature and the left atrium exist and provide a substrate for single or multiple reentry beats as a trigger for atrial fibrillation. In this trial, the investigators will examine the efficacy of elimination of distal connection(s) between coronary sinus and left atrial musculature for suppression of recurrent atrial arrhythmias.

NCT ID: NCT03646604 Active, not recruiting - Atopic Dermatitis Clinical Trials

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis

Start date: January 31, 2019
Phase: Phase 1
Study type: Interventional

The objective of this study is to evaluate the safety, pharmacokinetics and tolerability of multiple doses of upadacitinib in pediatric participants with severe atopic dermatitis and to evaluate palatability of upadacitinib oral solution in pediatric participants.